Teva Pharmaceutical Indus Analyst Ratings
CyberArk Software Analyst Ratings
CyberArk Software Analyst Ratings
CyberArk Software Analyst Ratings
Wedbush Reiterates Outperform on NICE, Maintains $250 Price Target
NICE Analyst Ratings
RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating
Wix.com Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
CyberArk Software Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Wix.com Analyst Ratings
CyberArk Software Analyst Ratings
CyberArk Software Analyst Ratings
Analysts Offer Insights on Technology Companies: Domo (DOMO) and CyberArk Software (CYBR)
CyberArk Software Analyst Ratings
CyberArk Software (CYBR) Gets a Buy From D.A. Davidson
Analysts Are Bullish on Top Technology Stocks: CyberArk Software (CYBR), MKS Instruments (MKSI)
CyberArk Software: Strong Buy Rating on Strategic Acquisition and Favorable Market Conditions
Wix.com Analyst Ratings